1. Medtech Insight
  2. >>Digital Technologies
  3. >>AI

Podcast Special: J&J's Andrie Leday Addresses ASC Market With Customized Approach

 
• By Reed Miller

In this special podcast from Medtech Insight, editor Reed Miller talked to Andrie Leday, the US vice president for ambulatory surgery centers (ASCs) at Johnson & Johnson/DePuy Synthes. Leday's group is dedicated to creating a new "ecosystem" around DePuy Synthes' broad range of orthopedic implants and tools to meet the demand of an aging population.

Medtech podcast
• Source: Alamy

The shift of orthopedic surgeries from hospitals to outpatient centers has accelerated in the last decade and is not likely to slow down soon, so orthopedic companies have to adapt to the demanding outpatient market segment.

“We're focused on the growth and clinical success of ASCs,” Andrie Leday, the US vice president for ambulatory surgery centers (ASCs) at Johnson & Johnson/DePuy Synthes, told Medtech...

According to the Ambulatory Surgery Center Association, about 6,100 ASCs perform an estimated 30 million procedures across a range of specialties in the US each year. Orthopedic surgery is...

More from AI

More from Digital Technologies

Thousands Of Cardiac Digital Twins Reveal Novel Connections With Mental Health

 
• By Natasha Barrow

King’s College London, Imperial College London and The Alan Turing Institute constructed cardiac digital twins at scale, creating over 3,400, in a new study using UK Biobank data published in Nature Cardiovascular Research on 16 May.

Synchron And Apple Team Up To Use ‘Mind-Thought Connection’ To Control iPhones, iPads

 
• By Marion Webb

Apple and Synchron are teaming up to develop technologies that will one day allow people who can’t use their hands or voice to control iPhones, iPads and other Apple devices by using only their thoughts.

Ketryx Wants Its Validated AI Agents To Accelerate Compliance Workflows

 
• By Shubham Singh

While the initial focus is medical devices and life sciences, Ketryx sees future opportunities in other high-regulation sectors including automotive, aerospace and defense, pharma manufacturing and nuclear systems.